The global tissue microarray market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The market is driven by factors such as increasing demand for tissue microarrays in research and development activities, growing number of clinical trials, and increasing adoption of tissue microarrays in drug discovery process.
Immunohistochemistry segment accounted for the largest share of the global tissue microarray market in 2018. Immunohistochemistry segment is expected to maintain its dominance throughout the forecast period due to its wide range of applications across various industries such as pharmaceuticals and biotechnology companies, research organizations, hospitals and laboratories. Fluorescent ISitu Hybridization segment accounted for the second-largest share in 2018 owing to its high accuracy rate when compared with other techniques such as immunohistochemistry or frozen sectioning technique.
- Tissue microarrays are used to diagnose cancer and other diseases.
- The market for tissue microarrays is expected to grow as the number of people diagnosed with cancer increases.
- Tissue microarrays are used in research and development, which will drive the market for tissue microarrays in the future.
- The use of tissue microarrays in research and development will lead to more accurate diagnoses, which will increase demand for tissue microarray products over time.
- The use of tissue arrays in research and development will also lead to new discoveries that can be applied clinically.
Industry Growth Insights published a new data on “Tissue Microarray Market”. The research report is titled “Tissue Microarray Market research by Types (Immunohistochemistry, Fluorescent In-Situ Hybridization, Frozen Tissue Array, Others), By Applications (Pharmaceutical and Biotechnological Companies, Research Organization, Others), By Players/Companies Bio-Techne, Applied Microarrays, Z Biotech, OriGene, BioCat, Bio SB, Creative Bioarray, Abcam, BioIVT, Externautics, Protein Biotechnologies, US Biomax Inc., Auria Biopankki”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Tissue Microarray Market Research Report
By Type
Immunohistochemistry, Fluorescent In-Situ Hybridization, Frozen Tissue Array, Others
By Application
Pharmaceutical and Biotechnological Companies, Research Organization, Others
By Companies
Bio-Techne, Applied Microarrays, Z Biotech, OriGene, BioCat, Bio SB, Creative Bioarray, Abcam, BioIVT, Externautics, Protein Biotechnologies, US Biomax Inc., Auria Biopankki
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
238
Number of Tables & Figures
167
Customization Available
Yes, the report can be customized as per your need.
Global Tissue Microarray Market Report Segments:
The global Tissue Microarray market is segmented on the basis of:
Types
Immunohistochemistry, Fluorescent In-Situ Hybridization, Frozen Tissue Array, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pharmaceutical and Biotechnological Companies, Research Organization, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bio-Techne
- Applied Microarrays
- Z Biotech
- OriGene
- BioCat
- Bio SB
- Creative Bioarray
- Abcam
- BioIVT
- Externautics
- Protein Biotechnologies
- US Biomax Inc.
- Auria Biopankki
Highlights of The Tissue Microarray Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Immunohistochemistry
- Fluorescent In-Situ Hybridization
- Frozen Tissue Array
- Others
- By Application:
- Pharmaceutical and Biotechnological Companies
- Research Organization
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Tissue Microarray Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A tissue microarray is a type of medical imaging that uses small pieces of tissue from different parts of the body to create a detailed image. This technology can be used to diagnose diseases or injuries, and can also be used to study how diseases or injuries affect the body's tissues.
Some of the major players in the tissue microarray market are Bio-Techne, Applied Microarrays, Z Biotech, OriGene, BioCat, Bio SB, Creative Bioarray, Abcam, BioIVT, Externautics, Protein Biotechnologies, US Biomax Inc., Auria Biopankki.
The tissue microarray market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Tissue Microarray Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Tissue Microarray Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Tissue Microarray Market - Supply Chain
4.5. Global Tissue Microarray Market Forecast
4.5.1. Tissue Microarray Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Tissue Microarray Market Size (000 Units) and Y-o-Y Growth
4.5.3. Tissue Microarray Market Absolute $ Opportunity
5. Global Tissue Microarray Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Tissue Microarray Market Size and Volume Forecast by Type
5.3.1. Immunohistochemistry
5.3.2. Fluorescent In-Situ Hybridization
5.3.3. Frozen Tissue Array
5.3.4. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Tissue Microarray Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Tissue Microarray Market Size and Volume Forecast by Application
6.3.1. Pharmaceutical and Biotechnological Companies
6.3.2. Research Organization
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Tissue Microarray Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Tissue Microarray Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Tissue Microarray Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Tissue Microarray Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Tissue Microarray Demand Share Forecast, 2019-2026
9. North America Tissue Microarray Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Tissue Microarray Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Tissue Microarray Market Size and Volume Forecast by Application
9.4.1. Pharmaceutical and Biotechnological Companies
9.4.2. Research Organization
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Tissue Microarray Market Size and Volume Forecast by Type
9.7.1. Immunohistochemistry
9.7.2. Fluorescent In-Situ Hybridization
9.7.3. Frozen Tissue Array
9.7.4. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Tissue Microarray Demand Share Forecast, 2019-2026
10. Latin America Tissue Microarray Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Tissue Microarray Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Tissue Microarray Market Size and Volume Forecast by Application
10.4.1. Pharmaceutical and Biotechnological Companies
10.4.2. Research Organization
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Tissue Microarray Market Size and Volume Forecast by Type
10.7.1. Immunohistochemistry
10.7.2. Fluorescent In-Situ Hybridization
10.7.3. Frozen Tissue Array
10.7.4. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Tissue Microarray Demand Share Forecast, 2019-2026
11. Europe Tissue Microarray Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Tissue Microarray Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Tissue Microarray Market Size and Volume Forecast by Application
11.4.1. Pharmaceutical and Biotechnological Companies
11.4.2. Research Organization
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Tissue Microarray Market Size and Volume Forecast by Type
11.7.1. Immunohistochemistry
11.7.2. Fluorescent In-Situ Hybridization
11.7.3. Frozen Tissue Array
11.7.4. Others
11.8. Bais Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Tissue Microarray Demand Share, 2019-2026
12. Asia Pacific Tissue Microarray Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Tissue Microarray Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Tissue Microarray Market Size and Volume Forecast by Application
12.4.1. Pharmaceutical and Biotechnological Companies
12.4.2. Research Organization
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Tissue Microarray Market Size and Volume Forecast by Type
12.7.1. Immunohistochemistry
12.7.2. Fluorescent In-Situ Hybridization
12.7.3. Frozen Tissue Array
12.7.4. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Tissue Microarray Demand Share, 2019-2026
13. Middle East & Africa Tissue Microarray Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Tissue Microarray Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Tissue Microarray Market Size and Volume Forecast by Application
13.4.1. Pharmaceutical and Biotechnological Companies
13.4.2. Research Organization
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Tissue Microarray Market Size and Volume Forecast by Type
13.7.1. Immunohistochemistry
13.7.2. Fluorescent In-Situ Hybridization
13.7.3. Frozen Tissue Array
13.7.4. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Tissue Microarray Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Tissue Microarray Market: Market Share Analysis
14.2. Tissue Microarray Distributors and Customers
14.3. Tissue Microarray Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Bio-Techne
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Applied Microarrays
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Z Biotech
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. OriGene
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. BioCat
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Bio SB
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Creative Bioarray
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Abcam
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. BioIVT
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Externautics
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Protein Biotechnologies
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. US Biomax Inc.
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Auria Biopankki
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
